EcoDrugPlus

Ribosomal Protein L13

Ensembl ID : ENSMMMG00000009384
Gene Symbol: RPL13
3 Cross references
269 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSMMMG00000000829
Gene Symbol: RPL18A
1 Cross references
180 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSMMMG00000019687
Gene Symbol: RPL19
3 Cross references
241 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSMMMG00000021415
Gene Symbol: RPL21
3 Cross references
154 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMMMG00000018042
Gene Symbol: RPL22
3 Cross references
89 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSMMMG00000012739
Gene Symbol: RPL24
2 Cross references
294 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSMMMG00000020399
Gene Symbol: RPL26
3 Cross references
190 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSMMMG00000004795
Gene Symbol: RPL27
3 Cross references
202 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSMMMG00000016275
Gene Symbol: RPL27A
3 Cross references
229 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSMMMG00000001659
Gene Symbol: RPL28
3 Cross references
182 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSMMMG00000001277
Gene Symbol: RPL29
2 Cross references
420 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSMMMG00000005001
Gene Symbol: RPL3
3 Cross references
279 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).